Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
暂无分享,去创建一个
M. Provinciali | R. Papa | C. Giuli | D. Postacchini | R. Galeazzi | T. Casoli | M. Balietti | P. Fattoretti | M. Malavolta | R. Giacconi | P. Fabbietti | F. Piacenza | A. Basso | L. Costarelli | L. Nisi | Lorenzo Nisi
[1] M. Kitazawa,et al. Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation. , 2019, Journal of molecular biology.
[2] C. Franceschi,et al. Sex-Specific Associations of Blood-Based Nutrient Profiling With Body Composition in the Elderly , 2019, Front. Physiol..
[3] Jianrong Xu,et al. Bis(9)-(−)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice , 2018, Translational Neurodegeneration.
[4] U. Kalinowska-Lis,et al. Zinc‐containing compounds for personal care applications , 2018, International journal of cosmetic science.
[5] N. Kokras,et al. Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease , 2018, Journal of clinical psychopharmacology.
[6] G. Pawelec,et al. Role of the peripheral innate immune system in the development of Alzheimer's disease , 2017, Experimental Gerontology.
[7] R. Stewart,et al. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis , 2018, Age and ageing.
[8] Zhan-You Wang,et al. Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies , 2017, Front. Aging Neurosci..
[9] A. Bush,et al. Extracellular Zn2+ Is Essential for Amyloid β1–42-Induced Cognitive Decline in the Normal Brain and Its Rescue , 2017, The Journal of Neuroscience.
[10] H. Uzun,et al. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] P. Sachdev,et al. Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus , 2017, Front. Aging Neurosci..
[12] M. Provinciali,et al. Main biomarkers associated with age-related plasma zinc decrease and copper/zinc ratio in healthy elderly from ZincAge study , 2017, European Journal of Nutrition.
[13] Y. Kakinuma,et al. Donepezil, an acetylcholinesterase inhibitor, attenuates LPS-induced inflammatory response in murine macrophage cell line RAW 264.7 through inhibition of nuclear factor kappa B translocation. , 2016, European journal of pharmacology.
[14] M. Kitazawa,et al. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[15] C. Gagliardi,et al. My Mind Project: the effects of cognitive training for elderly—the study protocol of a prospective randomized intervention study , 2016, Aging Clinical and Experimental Research.
[16] C. Gomes,et al. Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease , 2016, Oxidative medicine and cellular longevity.
[17] Miki Suzuki,et al. Excess influx of Zn2+ into dentate granule cells affects object recognition memory via attenuated LTP , 2015, Neurochemistry International.
[18] E. Ho,et al. Zinc deficiency enhanced inflammatory response by increasing immune cell activation and inducing IL6 promoter demethylation. , 2015, Molecular nutrition & food research.
[19] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[20] C. Cunningham,et al. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research , 2015, Alzheimer's Research & Therapy.
[21] Jia Sun,et al. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.
[22] I. Simonelli,et al. Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies. , 2015, Journal of Alzheimer's disease : JAD.
[23] J. Gómez-Ariza,et al. Homeostasis of metals in the progression of Alzheimer’s disease , 2014, BioMetals.
[24] P. Mecocci,et al. Clinical trials and late‐stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 , 2014, Journal of internal medicine.
[25] E. Gonos,et al. Micronutrient–gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A systematic review , 2014, Mechanisms of Ageing and Development.
[26] M. Oh,et al. Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. , 2014, Neurotoxicology.
[27] J. Molinuevo,et al. Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease , 2013, American journal of Alzheimer's disease and other dementias.
[28] R. Galeazzi,et al. Comparison of intracellular zinc signals in nonadherent lymphocytes from young-adult and elderly donors: role of zinc transporters (Zip family) and proinflammatory cytokines. , 2012, The Journal of nutritional biochemistry.
[29] L. Rink,et al. Repletion of zinc in zinc-deficient cells strongly up-regulates IL-1β-induced IL-2 production in T-cells. , 2012, Metallomics : integrated biometal science.
[30] G. Pawelec,et al. Immune profiling of Alzheimer patients , 2012, Journal of Neuroimmunology.
[31] Jan Hellemans,et al. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain. , 2012, Journal of Alzheimer's disease : JAD.
[32] P. Pasqualetti,et al. Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies. , 2011, Journal of Alzheimer's disease : JAD.
[33] F. Lattanzio,et al. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population , 2010, Biogerontology.
[34] B. Hu,et al. Trace amounts of copper exacerbate beta amyloid-induced neurotoxicity in the cholesterol-fed mice through TNF-mediated inflammatory pathway , 2009, Brain, Behavior, and Immunity.
[35] V. Pavlov,et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway , 2009, Brain, Behavior, and Immunity.
[36] P. Pasqualetti,et al. Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease , 2009, Neurology.
[37] I. Shmulevich,et al. Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling. , 2008, Rejuvenation research.
[38] M. Malavolta,et al. Zinc–gene interaction related to inflammatory/immune response in ageing , 2008, Genes & Nutrition.
[39] R. Hansen,et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis , 2008, Clinical interventions in aging.
[40] D. Salt,et al. Slc39a1 to 3 (subfamily II) Zip genes in mice have unique cell-specific functions during adaptation to zinc deficiency. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[41] E. Barrett-Connor,et al. Plasma trace elements and cognitive function in older men and women: The Rancho Bernardo study , 2008, The journal of nutrition, health & aging.
[42] C. Caruso,et al. Zinc and Inflammatory/Immune Response in Aging , 2007, Annals of the New York Academy of Sciences.
[43] K. Tracey. Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.
[44] A. Albores,et al. Early effects of surgery on zinc and metallothionein levels in female rats , 1999, Biological Trace Element Research.
[45] Lothar Rink,et al. Correlation between zinc status and immune function in the elderly , 2006, Biogerontology.
[46] T. Ganz,et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] D. Gambi,et al. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1β and interleukin-6 release from lymphocytes of Alzheimer's disease patients , 2005, Experimental Gerontology.
[48] W. Maret,et al. Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. , 2005, Journal of Alzheimer's disease : JAD.
[49] J. Marcusson,et al. Rivastigmine as a Modulator of the Neuronal Glutamate Transporter rEAAC1 mRNA Expression , 2004, Dementia and Geriatric Cognitive Disorders.
[50] R. Uzzo,et al. Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes , 2001, Apoptosis.
[51] A. Akaike,et al. Nicotinic Acetylcholine Receptor-Mediated Neuroprotection by Donepezil Against Glutamate Neurotoxicity in Rat Cortical Neurons , 2003, Journal of Pharmacology and Experimental Therapeutics.
[52] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[53] M. Molaschi,et al. Determination of selected trace elements in patients affected by dementia. , 1996, Archives of gerontology and geriatrics.
[54] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[55] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[56] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[57] M. Lawton,et al. Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .
[58] S. Katz,et al. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.